COLL COLLEGIUM PHARMACEUTICAL, INC
P/E
18.08
Forward P/E
4.787
Price/Sales
0.925
Beta
0.73
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Collegium Pharmaceutical’s third quarter 2026 revenue of $216.3M beat estimates behind record ADHD sales
Collegium Pharmaceutical reported record quarterly net revenue for the third quarter 2026, driven by significant expansion in its ADHD franchise which now...
Collegium Pharmaceutical Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
For the third quarter of 2026, analysts expect Collegium Pharmaceutical to report consensus revenue of approximately $216.03 million and adjusted EPS of $1.86,...